Carboxytherapy for Periorbital Dark Circles

Periorbital Disorder Clinical Trial

Official title:

Evaluation of the Use of Carboxytherapy in Periorbital Dark Circles

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04745078
• Other study ID #: 0104074
• Status: Completed
• Phase: N/A
• Start date: January 1, 2017
• Est. completion date: May 15, 2021

Study information

• Verified date: November 2021
• Source: Alexandria University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

the study evaluates carboxytherapy for the treatment of periorbital dark circles

Description:

two different concentrations of carboxytherapy administered to patients are compared regarding efficacy

Recruitment information / eligibility

• Status: Completed
• Enrollment: 80
• Est. completion date: May 15, 2021
• Est. primary completion date: April 1, 2021
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 60 Years

Eligibility

Inclusion Criteria:

• healthy individuals with dark circles

Exclusion Criteria:

• infections, scarring, pregnancy, allergy, on treatment for the condition.

Related Conditions & MeSH terms

• Periorbital Disorder

Intervention

Other:
• Caboxy30
carboxy30 to periorbital dark halos
• Caboxy60
carboxy60 to periorbital dark halos

Locations

Country	Name	City	State
Egypt	Faculty of Medicine,Alexandria University	Alexandria

Sponsors (1)

Lead Sponsor	Collaborator
Alexandria University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Improvement of Melanin index	change in melanin index of the dark circles	6 weeks
Primary	Improvement of erythema index	change in erythema index of the dark circles	6 weeks